SkyView Investment Advisors’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

SkyView Investment Advisors’s Portfolio IQMDU Stock Details IQMDU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$103K	–	827
2022 Q4	$103K	Hold	10,000	–	–	0.03%	359
2022 Q3	$101K	Hold	10,000	–	–	0.03%	395
2022 Q2	$101K	Hold	10,000	–	–	0.03%	427
2022 Q1	$101K	Hold	10,000	–	–	0.02%	447
2021 Q4	$102K	Buy	+10,000	New	+$101K	0.02%	431

Other funds holding IQMDU

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

BHWM

Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SkyView Investment Advisors's IQMDU Position: Q1 2023 in Review

SkyView Investment Advisors sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2023, closing a stake of 10,000 shares — an estimated $103K sold.

SkyView Investment Advisors first reported a position in IQMDU in Q4 2021 and held it in 5 quarters. The position peaked at $103K in Q4 2022. 6 funds tracked by Wall St. Rank hold IQMDU as of Q1 2023.

SkyView Investment Advisors reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
SkyView Investment Advisors sold 10,000 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2023, an estimated $103K.
SkyView Investment Advisors first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 5 quarters.
SkyView Investment Advisors's Intelligent Medicine Acquisition Corp. Unit position peaked at $103K in Q4 2022.
6 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2023.

Based on SkyView Investment Advisors's 13F filing for Q1 2023, filed 18 May 2023.